Zvonko Milicevic, M.D., Ph. D., is a senior medical fellow at Eli Lilly&Co involved in clinical drug development research. Before joining Lilly in 1998, he was the head of the Department for metabolic diseases, Institute of Diabetes, Endocrinology and Metabolism, Zagreb, Croatia. He also holds an associated professor title at the J.J. Strossmayer Medical School, Department of internal medicine, Osijek, Croatia. In his recent research, he has focused on development of new pharmaceutical therapeutics for treatment of type 2 diabetes mellitus, including mono- and multi-receptor incretin agonists and insulins.